Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Article in English, Russian | MEDLINE | ID: mdl-38054226

ABSTRACT

Glioma cell cultures are used in basic researches of tumor processes, personalized medicine for selecting treatment regimens depending on individual characteristics of patients and pharmacology for assessing the effectiveness of chemotherapy. Suppression of glioma culture growth without reduction of malignancy grade is common. Drug cancellation may be followed by substitution of precursor cells by more malignant clones. Therefore, analysis of culture cell malignancy grade is important. In the future, intraoperative analysis of glioma cell malignancy grade can be used to select individual therapy. OBJECTIVE: We analyzed the relationship between expression of marker genes TUBB3, CD133, CDK4, CDK6, CIRBP, DR4, DR5, EGFR, FGFR, FSHR, GDNF, GFAP, L1CAM, LEF1, MAP2, MDM2, MELK, NANOG, NOTCH2, OCT4, OLIG2, PDGFRA, PDGFA, PDGFB and SOX2 and glioma cell malignancy grade, as well as created appropriate prognostic model. MATERIAL AND METHODS: We analyzed expression of 25 marker genes in 22 samples of human glioma cultures using quantitative real-time PCR. Statistical analysis was performed using the IBM SPSS Statistics 26.0 software. We used the Kolmogorov-Smirnov and Shapiro-Wilk tests to assess distribution normality. Nonparametric Jonckheere-Terpstra and Spearman tests were applied. RESULTS: We obtained a prognostic model for assessing the grade III and IV glioma cell malignancy based on expression of marker genes MDM2, MELK, SOX2, CDK4, DR5 and OCT4. Predictive accuracy was 83% (Akaike information criterion -55.125).


Subject(s)
Glioma , Humans , Prognosis , Glioma/genetics , Receptor, Notch2/genetics , Receptor, Notch2/metabolism , Gene Expression , Proto-Oncogene Proteins c-mdm2/genetics , Proto-Oncogene Proteins c-mdm2/metabolism , Proto-Oncogene Proteins c-mdm2/therapeutic use , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Protein Serine-Threonine Kinases/therapeutic use , Cyclin-Dependent Kinase 4/genetics , Cyclin-Dependent Kinase 4/metabolism , Cyclin-Dependent Kinase 4/therapeutic use , RNA-Binding Proteins/genetics , RNA-Binding Proteins/therapeutic use , SOXB1 Transcription Factors/genetics , SOXB1 Transcription Factors/metabolism
2.
Bull Exp Biol Med ; 174(4): 518-522, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36899203

ABSTRACT

We compared the expression of the main glioblastoma oncogenes during therapy with doxorubicin (Dox) and Dox in nanoparticles based on a copolymer of lactic and glycolic acids (Dox-PLGA) at a delayed start of treatment. Late initiation of Dox-PLGA therapy of glioblastoma showed an increase in the expression of multiple drug resistance genes, such as Abcb1b and Mgmt, and a decrease in Sox2 expression. Increased expression of other oncogenes (Melk, Wnt3, Gdnf, and Pdgfra) were observed during both Dox and Dox-PLGA therapy. These changes indicate increased tumor aggressiveness and its resistance to cytostatics at the late start of therapy.


Subject(s)
Doxorubicin , Glioblastoma , Nanoparticles , Animals , Rats , Cell Line, Tumor , Doxorubicin/therapeutic use , Drug Carriers , Glioblastoma/drug therapy , Glioblastoma/genetics , Nanoparticles/therapeutic use , Oncogenes , Polylactic Acid-Polyglycolic Acid Copolymer , Disease Models, Animal , Pharmacogenomic Testing
3.
Article in Russian | MEDLINE | ID: mdl-35170278

ABSTRACT

BACKGROUND: Doxorubicin is a well-known antitumor drug that is not employed for chemotherapy of brain tumors. Indeed, doxorubicin does not penetrate across the blood-brain barrier in therapeutic concentrations. OBJECTIVE: To study the antitumor effect of doxorubicin combined with nitrosorbide on intracranial experimental glioblastoma 101/8 in rats. MATERIAL AND METHODS: Male Wistar rats (n=86) with intracranial implanted glioblastoma 101/8 received doxorubicin (i.v. 1.5 mg/kg thrice) alone or in combination with nitrosorbide (i.v or orally, 0.5 mg/kg thrice) in 2, 5 and 8 days after implantation. Efficacy was assessed considering survival and brain tumor volume in 14 days after tumor implantation. RESULTS: Combination of doxorubicin and nitrosorbide significantly increased survival (57% and 155%, respectively) and slowed down tumor growth (16±12 and 8±6 mm3, respectively) compared to doxorubicin alone. Effectiveness of nitrosorbide alone was trivial. CONCLUSION: Nitric oxide donor nitrosorbide considerably potentiated the antitumor effect of doxorubicin against intracranial 101/8 glioblastoma in rats.


Subject(s)
Brain Neoplasms , Glioblastoma , Animals , Brain Neoplasms/drug therapy , Doxorubicin/pharmacology , Glioblastoma/drug therapy , Isosorbide Dinitrate/pharmacology , Male , Nitric Oxide Donors/pharmacology , Rats , Rats, Wistar
4.
Izv Akad Nauk Ser Biol ; (4): 341-347, 2016 Jul.
Article in English, Russian | MEDLINE | ID: mdl-30251786

ABSTRACT

Transgenic clones of mouse embryonic stem cells of the RI line were -received by transfection of plasmid linear vectors. The changes in the transgene structure during its integration into the genome of the target cells were investigated. Displacements were found on the flanks of the integrated transgene. It was found that multicopy tandem structures are formed in head- -tail orientation at the transgene integration. It was noted that the number of copies of the integrated transgenes varies considerably, but the introduction of DNA fragments from the nuclear shells into the flanks of the transgene normalizes the number of its copies.


Subject(s)
Gene Dosage , Mouse Embryonic Stem Cells/metabolism , Transfection , Transgenes , Animals , Mice , Mice, Transgenic , Mouse Embryonic Stem Cells/cytology
5.
Ontogenez ; 39(3): 208-11, 2008.
Article in Russian | MEDLINE | ID: mdl-18634333

ABSTRACT

The survival of transgenic mouse embryos was studied as a function of the transgene structure. The data obtained indicate that the introduction of a chromosomal DNA fragment providing for the anchoring of interphase chromosomes on the nuclear envelope increases the efficiency of transgenesis in mice threefold due to their increased viability.


Subject(s)
Chromosomes, Mammalian/genetics , Embryo, Mammalian/metabolism , Gene Transfer Techniques , Interphase/physiology , Nuclear Envelope/metabolism , Transgenes/physiology , Animals , Chromosomes, Mammalian/metabolism , Embryo, Mammalian/cytology , Female , Male , Mice , Mice, Inbred CBA , Mice, Transgenic , Nuclear Envelope/genetics
6.
Genetika ; 35(2): 266-70, 1999 Feb.
Article in Russian | MEDLINE | ID: mdl-10495943

ABSTRACT

Six DNA fragments of interphase chromosomes isolated from nuclear envelopes of murine hepatocytes were cloned and sequenced. Analysis of their structural-functional organization suggests that these fragments are highly specified protein-nonencoding fractions of a eukaryotic genome. In the evolutionary process, they appear already in archaebacteria and may be "ancestral" for DNA sequences involved in structuring chromosomal domains (rosette-like structures) of tissue-specific genes. In their composition, these fragments have nucleotide sequences homologous to the repeats of the SINE and LINE families and to the satellite DNA of murine centromeres.


Subject(s)
Chromosomes/genetics , DNA/genetics , Nuclear Envelope/genetics , Sequence Analysis, DNA , Animals , Base Sequence , Chromosomes/ultrastructure , Interphase , Mice , Molecular Sequence Data , Nuclear Envelope/ultrastructure
8.
Biull Eksp Biol Med ; 98(10): 434-6, 1984 Oct.
Article in Russian | MEDLINE | ID: mdl-6388658

ABSTRACT

A single subcutaneous injection of a long-acting immobilized insulin preparation activated biosynthetic events in the liver and skin of the burnt animals and slowed down tissue degradation as evidenced by creatine excretion. This insulin preparation can be successfully used for the treatment of burnt patients in order to stimulate metabolism and maintain normoglycemia.


Subject(s)
Burns/drug therapy , Insulin/therapeutic use , Animals , Burns/metabolism , Cholinesterases/blood , Creatine/urine , Delayed-Action Preparations , Drug Evaluation, Preclinical , Liver/metabolism , Male , Rats , Skin/metabolism , Suspensions
SELECTION OF CITATIONS
SEARCH DETAIL
...